Financials

The Genius™ 3D Mammography™ exam¹ detects 20-65% more breast cancers compared to 2D mammography alone.²

Superior biopsy imaging using Genius 3D technology. Improved workflow results in faster procedures and an enhanced patient experience.

Provides high-quality clinical images that reveal the smallest fractures at the earliest stage—helping to keep patients strong and healthy. Horizon™ was designed to assess osteoporosis, obesity and aortic calcifications.

NovaSure endometrial ablation for abnormal uterine bleeding (AUB) can dramatically improve a woman’s comfort, confidence and quality of life. It is a safe, simple solution used by more than 3 million women since 2001.

The MyoSure procedure enables fast, safe removal of fibroids, polyps and retained products of conception in less than 15 minutes—without having to make a single incision. It enables convenient removal of intrauterine pathology under direct visualization.

Offers best-in-class automation and workflow for molecular diagnostics, giving laboratories greater freedom and flexibility with true walkaway processing and random access sampling. Delivers a broad menu of the most sensitive, accurate and precise assays.

Hologic developed the first FDA-cleared nucleic acid test for infectious diseases over 30 years ago. Today, our state-of-the-art Aptima assays quickly identify diseases like chlamydia, gonorrhea, trichomoniasis, bacterial vaginosis, HIV-1, HCV and HBV at early stages, often within days of infection.

Cervical cancer was the #1 cancer killer of women prior to the introduction of Pap screening, now it’s #14.3 Hologic’s ThinPrep liquid-based cytology test has revolutionized cervical cancer screening and is the leading cervical specimen collection product in the world.

The Brevera® breast biopsy system with CorLumina® imaging technology is the world’s first and only solution to combine tissue acquisition, real-time imaging, verification and advanced post-biopsy handling—all in one, integrated system.

Provides excellent image quality and system versatility for all extremity imaging needs. The system is designed to help minimize radiation by preventing patient and surgeon exposure to the unused area of the detector.

To help fight COVID-19, Hologic developed the Panther Fusion® and Aptima SARS-CoV-2 assays, and scaled up to produce 1.5 million tests a week. The tests run on the world’s largest installed base of more than 2,800 high-throughput instruments.